The CBS Evening News (12/21, story 9, 0:25, Pelley) reported “The specialty pharmacy linked to that deadly meningitis outbreak filed for chapter 11 bankruptcy protection today.” NBC Nightly News (12/22, story 7, 0:25, Holt) added that the Framingham, Massachusetts-based specialty pharmacy “is facing 130 lawsuits.”
        According to Reuters (12/22, McLaughlin, Humer), the NECC, in documents filed Friday with the US Bankruptcy Court for the District of Massachusetts, indicated it had between $1 million and $10 million in assets and less than $2.34 million in debts. Its biggest unsecured creditor, is McKesson Drug, to which the compounder owes $143,169, according to the bankruptcy filing. Also on Friday, the NECC said it would create a meningitis victims’ compensation fund.
        Bloomberg News (12/22, McCarty) added that NECC issued a statement, saying its “goal is to provide a greater, quicker, fairer payout to its creditors than they could achieve through piecemeal litigation.” Modern Healthcare (12/22, Subscription Publication) also covered the story.
Leave a Reply